Revvity, Inc. (RVTY)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for RVTY is $124.88, 18.2% below the last close of $152.64 on Oct 16, 2026; targets range from $103.72 to $164.48. Rating consensus: Hold.
Snapshot
- P/E72.7x
- P/E vs sector+158.2%
- P/E vs own+57.1%
- Target upside-18.2%
- ConsensusHold
- Market cap$17.03B
- FCF yield+3.3%
- Insiders-$1.29M
- Earnings in18d
- News0.00
Why it moved
Revvity, Inc. (RVTY) fell 1.3% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.4).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $152.64 · +62.9% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI59
- Support-17.6%
- Resistance—
- Off 52w high-3.0%
- Off ATH-23.2%
- 52w range$152.64
- Bollingerupper half
- MACD-0.97
- ATR+3.6%
- Volume0.7x
Analyst price targets
12 firms with a target in the last 12 months · last close $152.64 · as of Oct 16, 2026
Strong buy 0 · Buy 6 · Hold 11 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +1.3% year over year, free cash flow 24.8% of revenue, operating margin 12.2%.
| Q2 FY2026 | Jul 5, 2026 | $730M | 0.47 | $181M | 57.1% | 12.2% | 7.1% |
| Q1 FY2026 | Apr 5, 2026 | $711M | 0.36 | $95.28M | 54.5% | 10.7% | 5.7% |
| Q4 FY2025 | Dec 28, 2025 | $772M | 0.87 | $163M | 43.8% | 14.5% | 12.7% |
| Q3 FY2025 | Sep 28, 2025 | $699M | 0.40 | $120M | 53.6% | 11.7% | 6.7% |
| Q2 FY2025 | Jun 29, 2025 | $720M | 0.47 | $115M | 54.5% | 12.6% | 7.7% |
| Q1 FY2025 | Mar 30, 2025 | $665M | 0.34 | $112M | 56.5% | 10.9% | 6.4% |
| Q4 FY2024 | Dec 29, 2024 | $729M | 0.78 | — | 49.3% | 18.1% | 13.0% |
| Q3 FY2024 | Sep 29, 2024 | $684M | 0.76 | $126M | 56.3% | 15.0% | 13.7% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 2 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 3 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 4 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 5 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 6 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | |
| 7 | | $152.64 | -1.3% | -3.0% | -18.2% | 72.7 | $17.03B | |
| 8 |  | $300.15 | -2.0% | -3.4% | +3.1% | — | $14.46B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.